{"result": "\n{\n    \"title\": \"Vasopressin and Septic Shock Trial\",\n    \"summary\": \"The community centers around the use of vasopressin in a multicenter trial aimed at evaluating its effects on septic shock mortality. Key entities include vasopressin, norepinephrine, and the countries where the trial was conducted, such as Canada, Australia, and the United States. The trial's findings highlight both the therapeutic potential and the side effects associated with vasopressin.\",\n    \"rating\": 7.5,\n    \"rating_explanation\": \"The impact severity rating is high due to the significant implications of the trial's findings on medical practices and patient outcomes in septic shock treatment.\",\n    \"findings\": [\n        {\n            \"summary\": \"Vasopressin's role in septic shock treatment\",\n            \"explanation\": \"Vasopressin was a central focus in the trial, used as a treatment for patients with septic shock. The trial aimed to evaluate its effect on mortality, comparing it with norepinephrine. Vasopressin was administered as a low-dose infusion to manage septic shock and reduce the dosage of norepinephrine, highlighting its potential as a vasopressor agent [Data: Entities (331); Relationships (178, 496, 447, 806)].\"\n        },\n        {\n            \"summary\": \"Geographical scope of the trial\",\n            \"explanation\": \"The trial was conducted across multiple countries, including Canada, Australia, and the United States. This wide geographical scope underscores the trial's comprehensive approach and the collaborative efforts in evaluating vasopressin's efficacy in treating septic shock [Data: Entities (217); Relationships (79, 239, 652)].\"\n        },\n        {\n            \"summary\": \"Comparison with norepinephrine\",\n            \"explanation\": \"The trial compared vasopressin with norepinephrine, focusing on their impact on septic shock mortality. Vasopressin was associated with fewer cardiac arrests compared to norepinephrine, suggesting its potential advantage in certain clinical scenarios [Data: Relationships (806, 820, 807)].\"\n        },\n        {\n            \"summary\": \"Adverse effects associated with vasopressin\",\n            \"explanation\": \"While vasopressin showed therapeutic potential, it was also associated with several adverse effects, including mesenteric ischemia, digital ischemia, and hyponatremia. These side effects highlight the need for careful consideration and monitoring when using vasopressin in clinical settings [Data: Entities (677, 680, 678); Relationships (821, 824, 822)].\"\n        },\n        {\n            \"summary\": \"Trial registration and identification\",\n            \"explanation\": \"The trial was registered under the Current Controlled Trials number ISRCTN94845869, ensuring transparency and accountability in the research process. This registration is crucial for the validation and replication of the trial's findings [Data: Entities (661); Relationships (819)].\"\n        }\n    ]\n}", "input": "\nYou are an AI assistant that helps a human analyst to perform general information discovery. Information discovery is the process of identifying and assessing relevant information associated with certain entities (e.g., organizations and individuals) within a network.\n\n# Goal\nWrite a comprehensive report of a community, given a list of entities that belong to the community as well as their relationships and optional associated claims. The report will be used to inform decision-makers about information associated with the community and their potential impact. The content of this report includes an overview of the community's key entities, their legal compliance, technical capabilities, reputation, and noteworthy claims.\n\n# Report Structure\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\n\n# Example Input\n-----------\nText:\n\nEntities\n\nid,entity,description\n5,VERDANT OASIS PLAZA,Verdant Oasis Plaza is the location of the Unity March\n6,HARMONY ASSEMBLY,Harmony Assembly is an organization that is holding a march at Verdant Oasis Plaza\n\nRelationships\n\nid,source,target,description\n37,VERDANT OASIS PLAZA,UNITY MARCH,Verdant Oasis Plaza is the location of the Unity March\n38,VERDANT OASIS PLAZA,HARMONY ASSEMBLY,Harmony Assembly is holding a march at Verdant Oasis Plaza\n39,VERDANT OASIS PLAZA,UNITY MARCH,The Unity March is taking place at Verdant Oasis Plaza\n40,VERDANT OASIS PLAZA,TRIBUNE SPOTLIGHT,Tribune Spotlight is reporting on the Unity march taking place at Verdant Oasis Plaza\n41,VERDANT OASIS PLAZA,BAILEY ASADI,Bailey Asadi is speaking at Verdant Oasis Plaza about the march\n43,HARMONY ASSEMBLY,UNITY MARCH,Harmony Assembly is organizing the Unity March\n\nOutput:\n{{\n    \"title\": \"Verdant Oasis Plaza and Unity March\",\n    \"summary\": \"The community revolves around the Verdant Oasis Plaza, which is the location of the Unity March. The plaza has relationships with the Harmony Assembly, Unity March, and Tribune Spotlight, all of which are associated with the march event.\",\n    \"rating\": 5.0,\n    \"rating_explanation\": \"The impact severity rating is moderate due to the potential for unrest or conflict during the Unity March.\",\n    \"findings\": [\n        {{\n            \"summary\": \"Verdant Oasis Plaza as the central location\",\n            \"explanation\": \"Verdant Oasis Plaza is the central entity in this community, serving as the location for the Unity March. This plaza is the common link between all other entities, suggesting its significance in the community. The plaza's association with the march could potentially lead to issues such as public disorder or conflict, depending on the nature of the march and the reactions it provokes. [Data: Entities (5), Relationships (37, 38, 39, 40, 41,+more)]\"\n        }},\n        {{\n            \"summary\": \"Harmony Assembly's role in the community\",\n            \"explanation\": \"Harmony Assembly is another key entity in this community, being the organizer of the march at Verdant Oasis Plaza. The nature of Harmony Assembly and its march could be a potential source of threat, depending on their objectives and the reactions they provoke. The relationship between Harmony Assembly and the plaza is crucial in understanding the dynamics of this community. [Data: Entities(6), Relationships (38, 43)]\"\n        }},\n        {{\n            \"summary\": \"Unity March as a significant event\",\n            \"explanation\": \"The Unity March is a significant event taking place at Verdant Oasis Plaza. This event is a key factor in the community's dynamics and could be a potential source of threat, depending on the nature of the march and the reactions it provokes. The relationship between the march and the plaza is crucial in understanding the dynamics of this community. [Data: Relationships (39)]\"\n        }},\n        {{\n            \"summary\": \"Role of Tribune Spotlight\",\n            \"explanation\": \"Tribune Spotlight is reporting on the Unity March taking place in Verdant Oasis Plaza. This suggests that the event has attracted media attention, which could amplify its impact on the community. The role of Tribune Spotlight could be significant in shaping public perception of the event and the entities involved. [Data: Relationships (40)]\"\n        }}\n    ]\n}}\n\n\n# Real Data\n\nUse the following text for your answer. Do not make anything up in your answer.\n\nText:\n-----Entities-----\nhuman_readable_id,title,description,degree\n331,VASOPRESSIN,\"VASOPRESSIN is a hormone that was the focus of a multicenter, randomized, double-blind trial aimed at evaluating its effect on mortality in patients with septic shock. In this study, vasopressin was administered as a low-dose infusion to manage septic shock and reduce the dosage of norepinephrine. Additionally, vasopressin served as a vasopressor agent used as rescue therapy in the trial.\",13\n217,CANADA,\"Canada was one of the countries where both the study and the trial were conducted, with multiple centers participating in the research efforts.\",2\n681,CARDIAC ARREST,,2\n677,MESENTERIC ISCHEMIA,\"Mesenteric ischemia is a potential adverse effect associated with vasopressin and norepinephrine, involving reduced blood flow to the intestines\",2\n680,DIGITAL ISCHEMIA,\"Digital ischemia is a condition involving reduced blood flow to the fingers or toes, reported more frequently in the vasopressin group\",1\n678,HYPONATREMIA,\"Hyponatremia is a condition of low sodium levels in the blood, reported as a side effect of vasopressin\",1\n661,ISRCTN94845869,The Current Controlled Trials number for the vasopressin study,1\n\n\n-----Relationships-----\nhuman_readable_id,source,target,description,rank\n178,SEPTIC SHOCK,VASOPRESSIN,Vasopressin was tested and used as a treatment for patients with septic shock in a clinical trial.,83\n496,TRIAL,VASOPRESSIN,Vasopressin was used as rescue therapy in the trial,53\n447,MULTICENTER TRIAL,VASOPRESSIN,The trial was conducted to evaluate the effects of vasopressin on septic shock mortality,29\n79,AUSTRALIA,VASOPRESSIN,The vasopressin trial was conducted in Australia,26\n239,UNITED STATES,VASOPRESSIN,The vasopressin trial was conducted in the United States,24\n806,NOREPINEPHRINE,VASOPRESSIN,\"The trial investigated the effects of vasopressin and norepinephrine on patients with septic shock, specifically focusing on their impact on mortality. Both vasopressin and norepinephrine were compared in this study to determine their efficacy in treating septic shock.\",23\n652,CANADA,VASOPRESSIN,The vasopressin trial was conducted in Canada,15\n820,VASOPRESSIN,CARDIAC ARREST,Vasopressin was associated with fewer cardiac arrests compared to norepinephrine in this study,15\n821,VASOPRESSIN,MESENTERIC ISCHEMIA,Vasopressin is associated with the risk of mesenteric ischemia as a side effect,15\n823,VASOPRESSIN,SKIN NECROSIS,Vasopressin is associated with the risk of skin necrosis as a side effect,15\n824,VASOPRESSIN,DIGITAL ISCHEMIA,Vasopressin is associated with a higher incidence of digital ischemia compared to norepinephrine,14\n822,VASOPRESSIN,HYPONATREMIA,Vasopressin is associated with the risk of hyponatremia as a side effect,14\n819,VASOPRESSIN,ISRCTN94845869,ISRCTN94845869 is the trial number for the vasopressin study,14\n645,HIGH-FREQUENCY OSCILLATORY VENTILATION (HFOV),CANADA,Canada was one of the countries where the HFOV study was conducted,12\n807,NOREPINEPHRINE,CARDIAC ARREST,Norepinephrine was associated with more cardiac arrests compared to vasopressin in this study,12\n808,NOREPINEPHRINE,MESENTERIC ISCHEMIA,Norepinephrine is associated with the risk of mesenteric ischemia as a side effect,12\n\n\nThe report should include the following sections:\n\n- TITLE: community's name that represents its key entities - title should be short but specific. When possible, include representative named entities in the title.\n- SUMMARY: An executive summary of the community's overall structure, how its entities are related to each other, and significant information associated with its entities.\n- IMPACT SEVERITY RATING: a float score between 0-10 that represents the severity of IMPACT posed by entities within the community.  IMPACT is the scored importance of a community.\n- RATING EXPLANATION: Give a single sentence explanation of the IMPACT severity rating.\n- DETAILED FINDINGS: A list of 5-10 key insights about the community. Each insight should have a short summary followed by multiple paragraphs of explanatory text grounded according to the grounding rules below. Be comprehensive.\n\nReturn output as a well-formed JSON-formatted string with the following format:\n    {{\n        \"title\": <report_title>,\n        \"summary\": <executive_summary>,\n        \"rating\": <impact_severity_rating>,\n        \"rating_explanation\": <rating_explanation>,\n        \"findings\": [\n            {{\n                \"summary\":<insight_1_summary>,\n                \"explanation\": <insight_1_explanation>\n            }},\n            {{\n                \"summary\":<insight_2_summary>,\n                \"explanation\": <insight_2_explanation>\n            }}\n        ]\n    }}\n\n# Grounding Rules\n\nPoints supported by data should list their data references as follows:\n\n\"This is an example sentence supported by multiple data references [Data: <dataset name> (record ids); <dataset name> (record ids)].\"\n\nDo not list more than 5 record ids in a single reference. Instead, list the top 5 most relevant record ids and add \"+more\" to indicate that there are more.\n\nFor example:\n\"Person X is the owner of Company Y and subject to many allegations of wrongdoing [Data: Reports (1), Entities (5, 7); Relationships (23); Claims (7, 2, 34, 64, 46, +more)].\"\n\nwhere 1, 5, 7, 23, 2, 34, 46, and 64 represent the id (not the index) of the relevant data record.\n\nDo not include information where the supporting evidence for it is not provided.\n\nOutput:", "parameters": {"model": "gpt-4o", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 2000, "n": 1}, "history": null}